Phase 2 Antiphospholipid Syndrome (APS) Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)
Antiphospholipid Syndrome (APS)
National and Kapodistrian University of Athens20 enrolled1 locationNCT07584083
Recruiting
Phase 2
Effect of Belimumab on Antibody Titers in Primary APS Patients
Antiphospholipid Syndrome (APS)
Ruijin Hospital20 enrolled1 locationNCT06747312